Migraine and patent foramen ovale: exploring the association and a possible treatment option.

J Pak Med Assoc

Department of Biological and Biomedical Sciences, Aga Khan University Hospital, Karachi, Pakistan.

Published: August 2008

AI Article Synopsis

  • Migraine is a common headache disorder affecting 10-12% of people and is a significant cause of worldwide health issues.
  • Research indicates a high occurrence of patent foramen ovale (PFO) in migraine patients, particularly those with aura, suggesting PFO might contribute to migraine development.
  • Patients with migraines and PFO often report symptom relief after closing the PFO, leading to an exploration of this treatment approach in managing migraines.

Article Abstract

Migraine is a very common type of headache. With a prevalence of 10-12%, migraine ranks 19th among diseases causing worldwide morbidity. Number of studies have shown a high prevalence of patent foramen ovale (PFO) in patients with migraine, especially migraine with aura. The right to left shunting of blood in a PFO could serve as a conduit for chemicals that would exert a trigger effect on hyper excitable neurons leading to the development of migraine. Furthermore patients with PFO and migraine also show a marked improvement in their symptoms after percutaneous closure of the PFO. This review is a close look at this association and also explores whether subsequent closure of the shunt can be looked upon as a viable treatment option.

Download full-text PDF

Source

Publication Analysis

Top Keywords

patent foramen
8
foramen ovale
8
treatment option
8
migraine
7
migraine patent
4
ovale exploring
4
exploring association
4
association treatment
4
option migraine
4
migraine common
4

Similar Publications

Background: Annually, approximately 7.6 million individuals experience a new ischemic stroke, and roughly 25% of all ischemic strokes are cardiogenic in origin, carrying a high risk of recurrence, death and disability. To prevent future ischemic strokes, especially in younger individuals, it is crucial to detect and treat direct and indirect cardioembolic sources.

View Article and Find Full Text PDF

Arrhythmias Following Patent Foramen Ovale Closure: An Unsolved Enigma.

Life (Basel)

December 2024

First Department of Cardiology, Hippokration Hospital, Athens Medical School, National and Kapodistrian University of Athens, Vas. Sofias 114, 11527 Athens, Greece.

Patent foramen ovale (PFO) closure has proven to be an effective method of reducing the risk of recurrent stroke in patients with embolic stroke of unknown origin (ESUS). One of the most recognized post-procedural complications is the de novo occurrence of supraventricular arrhythmias, mainly atrial fibrillation, in the first three months following PFO closure. Earlier studies reported the incidence to be around 3.

View Article and Find Full Text PDF

The relationship between left atrial enlargement (LAE) and primary cryptogenic stroke (PCS) remains a mystery. LAE has been proposed to be an independent risk factor of PCS, recurrent ischemic strokes, paroxysmal atrial fibrillation, and thromboembolism. Our study evaluates the prevalence of LAE among patients with PCS in the absence of atrial fibrillation, unlike previous studies that included atrial fibrillation, in order to isolate LAE as a risk factor.

View Article and Find Full Text PDF

Objective: This study aims to evaluate the short-term efficacy of right-to-left shunt closure in vestibular migraine patients, and compare the efficacy between patent foramen ovale (PFO) closure and pulmonary arteriovenous malformation (PAVM) embolization. Additionally, the study identifies factors related to surgical outcomes.

Methods: Forty-one patients with vestibular migraine and medium to large right-to-left shunts underwent surgery: PFO closure, PAVM embolization, or both.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!